Antibiotic misuse fuels drug resistance, experts warn
Armref Health Africa Country Director Dr.Meshack Ndirangu during the launch of the International Centre for Antimicrobial Resistance Solutions…
GLP-1 medications beyond weight loss: how far could their benefits extend?
Few drugs in recent history have made as big a splash as GLP-1–based therapies. First developed for type…
Common Medications May Change Your Gut for Years After You Stop Taking Them
Many commonly prescribed medications may leave long-lasting changes in the bacteria that live in the gut, according to…
‘Mad honey’ that can stop your heart is now being sold online worldwide
A few months ago, a friend of mine told me that his father-in-law had been rushed to the…
Scientists are one step closer to an ‘exercise pill’ – here’s what it could actually do
If exercise isn’t exactly your favourite way to spend your free time, the idea of getting some of…
Why aloe vera remains a timeless skincare ingredient
The world of skin care has never been so exciting. Every couple of months there is something new…
4 new opioid earmarks totaling $451,112 recommended
Four new opioid earmarks totaling $451,112 will be recommended to Luzerne County Council, the county’s Commission on…
Champion antibiotic prescribing group exceeds target milestones
More than 90% of eligible practices have engaged with Arwain DGC’s Veterinary Prescribing Champion network. Share Veterinary Prescribing…
New weight loss drug may burn fat without muscle loss seen in GLP-1 drugs
(NewsNation) — Researchers at UC Berkeley say they have identified a new compound that may help the body burn…
FDA Expands Label of Oral HIV Drug to Newborns
The FDA expanded the approval of dolutegravir tablets for oral suspension (Tivicay PD) to include newborns with HIV…
Stage 4 Maine cancer patient says new FDA-approved pill is buying him time
PORTLAND, Maine (WGME) — It’s potentially new hope for pancreatic cancer patients. The FDA has just given approval…
Central Oregon patients gain access to newly approved breakthrough cancer medication
CENTRAL OREGON (KTVZ) — The Food and Drug Administration approved daraxonrasib Aug. 26, offering a new treatment option…